|Renee Leck||Director, Investor Relations|
|Mark Rothera||President, Chief Executive Officer|
|Bobby Gaspar||Chief Scientific Officer|
|Frank Thomas||Chief Financial Officer and Chief Business Officer|
|Graig Suvannavejh||Goldman Sachs|
|Anupam Rama||JP Morgan|
|David Nierengarten||Wedbush Securities|
Good day, ladies and gentlemen, and welcome to the Orchard Therapeutics Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, there will be a question and answer session and instructions will follow at that time. [Operator instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to Renee Leck, Director of Investor Relations.